The Pitfalls of Performance Chasing Why LongTerm Strategy Matters Over ShortTerm Returns Venture Capital Turns to Boring Businesses AI Meets Accounting and Property Management Gold Prices Hold Steady as Markets Eye USIran Peace Talks Snowflake Surges 36 on Earnings Beat Announces 6 Billion AWS Cloud Spending Plan New York Times Wordle Continues Daily Engagement Milestone With Puzzle 1799 Fed Minutes Signal Potential Rate Hikes if Inflation Persists Amid Geopolitical Tensions CXDO Q1 2026 Earnings EPS Surprises 256 Above Estimates AVA Q1 2026 Earnings Earnings Per Share Beat Estimates as Utility Operations Remain Steady AGAE Q1 2025 Earnings Negative EPS of 011 Amid Silent Guidance and Market Decline cbdMD Inc YCBD Q1 2026 Earnings WiderThanExpected Loss Highlights Ongoing Challenges PAGP Q1 2026 Earnings Strong EPS Surprise of 11972 Beats Estimates Marathon Petroleum Corporation MPC Q1 2026 Earnings Massive EPS Beat Surprises Analysts Vendome Acquisition Corporation I VNME Holds Steady at 1017 SPAC Stability in Focus Greenwave Technology Solutions GWAV Slips 382 as Selling Pressure Tests Key Support Waton Financial WTF Tests Key Support After 149 Decline Pagaya Technologies PGY Slips 191 as Shares Test Key Support Zone DR Horton DHI Edges Higher as Homebuilder Shares Find Support White House Announces China to Buy 17 Billion in US Agricultural Goods Annually Rare Earths Access in TrumpXi Summit Outcomes BRAG Q1 2026 Earnings NarrowerthanExpected Loss Highlights Operational Progress Delek US Holdings DK Surges Over 25 as Stock Approaching Key Resistance MAS Overhauls Complex Product Rules as Retail Investors Gain Sophistication India Gains from Data Center Expansion While Largely Missing AI Chip Boom DeepSeek Chinese AI Model Earns Silicon Valley Praise Despite Chip Hurdles Pope Leo Warns AI Needs to Be Disarmed Citing ProfitDriven Risks Professional Title Medicare Fraud Conviction CEO Sentenced in 1 Billion Scheme Targeting Seniors Wholesale Inflation Surges 6 Annually in April Marking Sharpest Rise Since 2022 Health Ministry Reclassifies CNS Drug Pregabalin to Schedule H1 to Curb Misuse